Life Science Industry News

14 July 2003 - Immunotoxicology - enhanced testing programme launched

Southern Research Institute adds new services to help meet industry’s immunotoxicology guidelines Concerns about medicinal products interfering with the..  More >>

04 July 2003 - Europe steps up disease prevention effort with €9 million for SARS research

Commission investing €9 million to fund research into SARS prevention: first tranche of €1.11bn ’to combat major diseases’ Initiative should ’pave way..  More >>

30 June 2003 - New, once weekly beta-interferon treatment for MS approved in Europe

Biogen - Avonex prefilled syringe approval by EMEA Treatment for patients with multiple sclerosis ’even more convenient.’ The European Agency for Evaluation..  More >>

27 June 2003 - €1.2m funding for biomanufacturing development in Wales

Protherics plc wins £800,000 grant from Welsh Assembly Government to help finance development of manufacturing facility Cheshire, UK based biopharma..  More >>

27 June 2003 - New treatment for Parkinson's enters Phase III

SkyePharma’s OCR formulation of GSK’s Requip begins Phase III clinical trials SkyePharma plc’s oral controlled release formulation of GlaxoSmithKline’s..  More >>

26 June 2003 - Controlling bad cholesterol with a daily 'cap of tea'

Clinical trial shows LDL cholesterol lowering effect of green tea extract Ever since the 1960s there have been sporadic and, at times, anecdotal reports of..  More >>

24 June 2003 - Cambrex opens new biopharmaceutical process development facility

Cambrex Bio Science offers complete optimization  for early-stage biomanufacturing development Cambrex Bio Science Baltimore, Inc. unveiled its new..  More >>

23 June 2003 - New containment facility for high potency API development

Solutia Pharmaceutical Services Division (Solutia PSD) completes containment facility in Bubendorf, Switzerland. The facility supports Solutia’s newest Centre..  More >>

23 June 2003 - Avant Immunotherapeutics rejigs CholeraGarde vaccine production

Avant Immunotherapeutics, Inc. based in Needham, Mass is terminating its manufacturing contract with Bio Sidus, S.A., of Buenos Aires, Argentina, for the..  More >>

17 June 2003 - Safety of blood products: Intercept system inactivates virus of SARS family

Preliminary tests show that a new pathogen inactivation technology is effective against the human coronavirus Companies engaged in the processing and supply..  More >>

17 June 2003 - Valentis backs out of pAlliance - gets back on track with DSM

Valentis resumes earlier licence agreement with DSM Biologics and is granted two manufacturing patents A new deal between Valentis and DSM Biologics..  More >>

06 June 2003 - Thalidomide - potential therapy for cancer highlighted at ASCO.

Celgene Corp. reveals new data from clinical trials of Thalomid® in solid tumour cancers Clinical investigators from leading cancer research centers around..  More >>